|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: JHDM1D-AS1 |
Gene summary for JHDM1D-AS1 |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | JHDM1D-AS1 | Gene ID | 100134229 |
| Gene name | KDM7A divergent transcript | |
| Gene Alias | JHDM1D-AS1 | |
| Cytomap | 7q34 | |
| Gene Type | ncRNA | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 100134229 | JHDM1D-AS1 | C04 | Human | Oral cavity | OSCC | 8.47e-18 | 6.77e-01 | 0.2633 |
| 100134229 | JHDM1D-AS1 | C21 | Human | Oral cavity | OSCC | 1.93e-05 | 2.99e-01 | 0.2678 |
| 100134229 | JHDM1D-AS1 | C30 | Human | Oral cavity | OSCC | 4.85e-20 | 6.92e-01 | 0.3055 |
| 100134229 | JHDM1D-AS1 | C43 | Human | Oral cavity | OSCC | 1.54e-14 | 3.22e-01 | 0.1704 |
| 100134229 | JHDM1D-AS1 | C57 | Human | Oral cavity | OSCC | 9.85e-22 | 5.74e-01 | 0.1679 |
| 100134229 | JHDM1D-AS1 | C06 | Human | Oral cavity | OSCC | 9.72e-05 | 7.80e-01 | 0.2699 |
| 100134229 | JHDM1D-AS1 | C08 | Human | Oral cavity | OSCC | 3.97e-21 | 4.55e-01 | 0.1919 |
| 100134229 | JHDM1D-AS1 | LN46 | Human | Oral cavity | OSCC | 4.03e-04 | 2.46e-01 | 0.1666 |
| 100134229 | JHDM1D-AS1 | SYSMH1 | Human | Oral cavity | OSCC | 3.76e-10 | 2.54e-01 | 0.1127 |
| 100134229 | JHDM1D-AS1 | SYSMH2 | Human | Oral cavity | OSCC | 4.92e-14 | 3.67e-01 | 0.2326 |
| 100134229 | JHDM1D-AS1 | SYSMH3 | Human | Oral cavity | OSCC | 9.69e-20 | 4.39e-01 | 0.2442 |
| 100134229 | JHDM1D-AS1 | SYSMH5 | Human | Oral cavity | OSCC | 3.01e-04 | 1.33e-01 | 0.0647 |
| 100134229 | JHDM1D-AS1 | SYSMH6 | Human | Oral cavity | OSCC | 3.71e-12 | 2.53e-01 | 0.1275 |
| Page: 1 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Oral Cavity |  | EOLP: Erosive Oral lichen planus |
| LP: leukoplakia | ||
| NEOLP: Non-erosive oral lichen planus | ||
| OSCC: Oral squamous cell carcinoma |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Stomach | WIM |  |
| Stomach | SIM |  |
| Liver | NAFLD |  |
| Liver | Cirrhotic |  |
| Liver | HCC |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| Page: 1 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| Page: 1 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |